Fingerprint
Dive into the research topics of 'Chronic phase of ETV6-ABL1 positive CML responds to imatinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Chronic phase of ETV6-ABL1 positive CML responds to imatinib
Norihiko Kawamata, Azadeh Dashti, Daning Lu, Becky Miller, H. Phillip Koeffler, Rhona Schreck, Stephen Moore, Seishi Ogawa
Research output: Contribution to journal › Letter › peer-review
20
Scopus
citations